|
Categories |
|
Biotechnology |
|
|
Biotechnology
Cancer
Consumer
Customer
Relationship Management
Drug
Delivery
eHealthcare
Pharma
eHealthcare
Physician
Generics
Healthcare
Medical
Devices
OTC
Pharmaceuticals
Pharmaceuticals
Pharmacoeconomics
Therapeutic
Areas:
- Cardiovascular
- Central
Nervous System
- Immune
Disorders and Inflammation
- Infectious
Diseases
- Oncology
-
Women'sHealth
|
|
|
1- The Biotechnology Market Outlook: Growth opportunities and effective strategies 1-Nov-2005
------------------------------------------------------------------------------------------------------------------------- |
2- The Top 10 Biotechnology Companies 1-Aug-2005
This new report will help you to identify the critical success factors that have driven company growth, evaluate diversification opportunities and assess the future potential of each company’s R&D portfolio over the next five years.
------------------------------------------------------------------------------------------------------------------------- |
3- Future Growth Strategies: Drivers of sustainable
development within the biotech, specialty and major pharma
sectors Jan-2004
This report assesses favored growth strategies for
pharma and biotechs and offers productive solutions to assure
long-term success.
-------------------------------------------------------------------------------------------------------------------------
|
4- The Outlook For The Biotech Sector In The Post-Genomic
Era: Strategies for drug discovery, diagnostics and personalized
medicine 3-Mar-2003
An important
milestone in the genomic era was reached in February 2001, when the
Human Genome Project and Celera Genomics presented the initial
sequencing and analysis of the human genome.
-------------------------------------------------------------------------------------------------------------------------
|
5- Oncology Review 2002 - Biotechnology Niche Product
Positioning Begins to Sharpen the Oncology
Marketplace
20-Feb-2003
Key market events,
successful marketing strategies, and changing market
expectations.
-------------------------------------------------------------------------------------------------------------------------
|
6- Strategic Perspectives: Malignant Melanoma -
Biotechnology-Driven Agents Finding a Flagship Indication?
20-Feb-2003
Diagnosis and treatment of melanoma in eight major
markets, and predictions for current and pipeline product dynamics
through 2010.
-------------------------------------------------------------------------------------------------------------------------
|
7- Emerging Biotechnology Players: From Innovation to
Realization 27-Jun-2003
Current and future
dynamics of the emerging biotechnology sector, assessing the winners
and losers to 2007.
-------------------------------------------------------------------------------------------------------------------------
|
| |
| |
| |
